Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2014 01:44 ET | Source: Evotec AG

Evotec AG Reports Results of First Quarter 2014

CONTINUING TO ACCELERATE INNOVATION EFFICIENCY STRATEGY IN NEWLY SEGMENTED BUSINESS FORMATION HAMBURG, Germany, May 14, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX)...
May 07, 2014 07:40 ET | Source: Evotec AG

Evotec to Report First Quarter 2014 Results on 14 May 2014

HAMBURG, Germany, May 7, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) will report its financial results for the first quarter of 2014 on Wednesday, 14 May...
May 06, 2014 01:38 ET | Source: Evotec AG

Evotec and Eternygen Enter Collaboration to Identify and Develop Novel Metabolic Disease Therapy

BERLIN and HAMBURG, Germany, May 6, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Eternygen GmbH, a privately owned biopharmaceutical company, today announced a...
April 24, 2014 01:37 ET | Source: Evotec AG

Evotec Receives First Milestone in Roche Biomarker Collaboration

HAMBURG, Germany, April 24, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced the successful achievement of a milestone in its biomarker...
April 02, 2014 01:39 ET | Source: Evotec AG

Evotec and Debiopharm Group(TM) to Collaborate on Development of New Treatment for Cancer

Innovative partnership based on one of Evotec's Target X projects Evotec and Debiopharm to share discovery and development efforts LAUSANNE, Switzerland and HAMBURG, Germany, April 2,...
March 31, 2014 01:40 ET | Source: Evotec AG

Evotec and Convergence Form Integrated Pain Alliance

HAMBURG, Germany, March 31, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has entered into a research alliance with Panion Ltd, a subsidiary...
March 25, 2014 02:58 ET | Source: Evotec AG

Evotec FY 2013: Execute on Innovate to Create Value

HAMBURG, Germany, March 25, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced its financial results for the fiscal year ended 31 December 2013, which are...
March 24, 2014 02:40 ET | Source: Evotec AG

Evotec Acquires Bionamics GmbH to Accelerate "EVT Innovate" Strategy

Expanding discovery pipeline with portfolio of projects especially in Multiple Sclerosis and CNS Appointment of Dr Timm Jessen as "EVP Business Development EVT Innovate" to further enhance...
March 18, 2014 09:28 ET | Source: Evotec AG

Evotec AG: Fiscal Year 2013 Results Presentation on 25 March 2014

HAMBURG, Germany, March 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for 2013 on Tuesday, 25 March 2014. The...
December 17, 2013 01:40 ET | Source: Evotec AG

Evotec and Yale University to Collaborate on Cancer Therapy

First collaboration within open innovation alliance with Yale University Collaborative effort will explore novel mechanisms, targets and compounds that have the potential to interfere with...